SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Samuel Seward who wrote (2285)2/10/1998 2:45:00 PM
From: Tokyo VD  Respond to of 7041
 
Sam,

The stock is probably up in response to the Merrill Lynch meeting today where Pfizer spoke about the size of the market.

Also contributing is the fact that Cowen is giving Zonagen and its mouthpiece, Irwin Goldstein, a Monday morning slot at its annual healthcare conference held in Boston in March.

(Yes, Dauntless, I'm still bitter about the lack of an NDA filing)
Tokyo